You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
研報掘金丨國投證券:首予百利天恆“買入-A”評級,目標價399.56元

國投證券研報指出,看好百利天恆(688506.SH)EGFR×HER3 雙抗ADC海外市場放量潛力,ADC+多抗龍頭崛起值得期待。公司EGFR×HER3雙抗ADC已授權海外MNC 大藥企BMS,考慮到其已披露的優異臨牀數據以及BMS在腫瘤藥物領域的優勢地位,看好其海外市場銷售放量。此外,公司已在ADC與多抗領域做了深度佈局,多個全球首創的ADC與多抗已進入臨牀階段,後續進展值得期待。採取DCF估值方法得到的公司價值約爲1602億元,對應12個月目標價399.56元,首次給予“買入-A”的投資評級。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account